Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3000388rdf:typepubmed:Citationlld:pubmed
pubmed-article:3000388lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0074587lld:lifeskim
pubmed-article:3000388lifeskim:mentionsumls-concept:C0130819lld:lifeskim
pubmed-article:3000388pubmed:issue10lld:pubmed
pubmed-article:3000388pubmed:dateCreated1986-1-15lld:pubmed
pubmed-article:3000388pubmed:abstractTextA sigma-opioid receptor ligand, N-allylnormetazocine (SKF 10047), binds specifically and reversibly to rat liver membranes. The rat liver binding sites for SKF 10047 are similar to sigma-opioid CNS receptors. They fail to interact with classical opiates (morphine, naloxone) and opioid peptides but bind with high affinity benzomorphans (bremazocine, SKF 10047) and various psychotropic drugs (haloperidol, imipramine, phencyclidine etc).lld:pubmed
pubmed-article:3000388pubmed:languageruslld:pubmed
pubmed-article:3000388pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:citationSubsetIMlld:pubmed
pubmed-article:3000388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3000388pubmed:statusMEDLINElld:pubmed
pubmed-article:3000388pubmed:monthOctlld:pubmed
pubmed-article:3000388pubmed:issn0132-3423lld:pubmed
pubmed-article:3000388pubmed:authorpubmed-author:VinogradovV...lld:pubmed
pubmed-article:3000388pubmed:authorpubmed-author:IaryginK NKNlld:pubmed
pubmed-article:3000388pubmed:authorpubmed-author:SamovilovaN...lld:pubmed
pubmed-article:3000388pubmed:issnTypePrintlld:pubmed
pubmed-article:3000388pubmed:volume11lld:pubmed
pubmed-article:3000388pubmed:ownerNLMlld:pubmed
pubmed-article:3000388pubmed:authorsCompleteYlld:pubmed
pubmed-article:3000388pubmed:pagination1380-4lld:pubmed
pubmed-article:3000388pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:meshHeadingpubmed-meshheading:3000388-...lld:pubmed
pubmed-article:3000388pubmed:year1985lld:pubmed
pubmed-article:3000388pubmed:articleTitle[Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].lld:pubmed
pubmed-article:3000388pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3000388pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3000388pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3000388pubmed:publicationTypeEnglish Abstractlld:pubmed